News, views and contacts from the global Pharmaceutical industry
26 February 2017
Industry News

US FDA awards orphan drug designation to Minoryx’s MIN-102 compound
The US Food and Drug Administration (FDA) has granted orphan drug designation to Minoryx Therapeutics’ lead compound MIN-102.

M&As this week: Zhejiang Conba Pharmaceutical, Biolennia Laboratories
Zhejiang Conba Pharmaceutical has sold 57.3% stake in a pharmaceutical company for ¥345.1m ($50.27m).

Deals this week: Affigen, Albany Molecular Research, Bristol-Myers Squibb
In a series A venture financing round, US-based biotechnology company Affigen has raised $17m to be utilised for advancing the company’s lead programmes in a number of haematological malignancies through pre-clinical validation and into phase I clinical studies.

Abivax to screen new antiviral molecules to develop therapeutic candidates against dengue fever
French biotechnology company Abivax has discovered new antiviral molecules and is screening them to develop therapeutic candidates against dengue fever.

Press Releases

A year when change brings opportunity
What will 2017 hold? Zenith Technologies has been looking forward to the future and discussing what its industry experts predict will happen.

Importance of Particle Size and Shape to Powder Bed Additives Packing Behaviour and Processing
Packing density and flow behaviour of metal powders has an effect on manufacturing efficiency of powder bed additives.

CurTec's Pharma-Grade Packo
CurTec's small volume container Pharma Grade Packo has been tested in accordance to both EU and US Pharmacopeia standards and is suitable as primary packaging for pharmaceuticals.

ASPYRA Picture Archiving and Communication System (PACS) Receives CE Mark
ASPYRA has announced it has received a CE Mark on its picture archiving and communication system (PACS) products, including MedVIEW with AccessNET.

Early Involvement of Automation Partner in Point-of-Care (POC) Product Development Pays Off
Interaction between system planning and product optimisa-tion enables costs for subsequent series production of point-of-care products to be reduced and punctual ramp-ups to be ensured.

White Papers

Packaging Solutions for the Medical Device and Pharmaceutical Industry
Plastiape manufactures a large range of polymers, including acrylonitrile butadiene styrene (ABS), polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), and polyoxymethylene...

Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test
The E-Scan 655 tests container closure integrity in syringes, vials, and other liquid-filled parenteral...

Efficient Synthesis Development
It is impossible to imagine operations and development research without keywords, such as quality be design (QbD), design of experiments (DoE) or established parameter ranges...

Klocke uses NA and ML for Quality Storage
The KLOCKE Group manufactures and packages pharmaceutical products, food supplements and cosmetic...

Child Safe Compliance Packaging Wherever You Are in the World
Origin Pharma's lightweight child-resistant closure provides an effective line of defense against child access to pharmaceuticals....

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties. is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.